Moderna Inc (MRNA)

[axelvento]

There is no doubt Moderna is one of the best Biotech!

Food and Drug Administration (FDA) plan to meet as late as the end of June to figure out which variants of the virus should be targeted with boosters intended for use in the fall.



-May 4 the U.S. government hasn't allocated money in the budget to buy booster doses of any version of Spikevax for the anticipated fall surge. If this situation doesn't resolve soon, to continue selling its jab, the biotech could sell it directly to individuals, pharmacies, and insurers.

the price per dose for the 2023 fiscal year could be in the $60 range. That's quite an increase compared to the price of around $16.50 per dose that the U.S. government has paid the company since the start of the pandemic.

$MRNA money machine!!!!!!!!